Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 09, 2020

SELL
$49.47 - $53.77 $125,455 - $136,360
-2,536 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$42.91 - $52.5 $3,690 - $4,515
86 Added 3.51%
2,536 $129,000
Q4 2019

Feb 14, 2020

SELL
$44.25 - $50.86 $14,204 - $16,326
-321 Reduced 11.58%
2,450 $123,000
Q2 2019

Aug 14, 2019

SELL
$40.43 - $44.3 $7,681 - $8,417
-190 Reduced 6.42%
2,771 $120,000
Q1 2019

May 13, 2019

BUY
$40.83 - $45.43 $120,897 - $134,518
2,961 New
2,961 $131,000
Q1 2019

May 03, 2019

SELL
$40.83 - $45.43 $124,980 - $139,061
-3,061 Closed
0 $0
Q3 2018

Oct 29, 2018

SELL
$40.0 - $44.84 $220,320 - $246,978
-5,508 Reduced 64.28%
3,061 $136,000
Q2 2018

Aug 03, 2018

SELL
$37.63 - $41.22 $96,746 - $105,976
-2,571 Reduced 23.08%
8,569 $343,000
Q1 2018

Apr 23, 2018

BUY
$38.98 - $45.76 $121,305 - $142,405
3,112 Added 38.76%
11,140 $446,000
Q4 2017

Feb 12, 2018

SELL
$42.86 - $50.61 $136,166 - $160,787
-3,177 Reduced 28.35%
8,028 $346,000
Q3 2017

Nov 01, 2017

BUY
$47.04 - $50.34 $482,254 - $516,085
10,252 Added 1075.76%
11,205 $558,000
Q3 2017

Oct 23, 2017

BUY
$47.04 - $50.34 $44,829 - $47,974
953
953 $47,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Financial Architects, Inc Portfolio

Follow Financial Architects, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.